Skip to main content
Clinical Trials/ISRCTN18337380
ISRCTN18337380
Completed
未知

Evaluation of the clinical and cost­ effectiveness of Short-­term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced long-term Neurological conditions (OPTCARE Neuro)

King's College London0 sites350 target enrollmentJanuary 21, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Topic: Dementias and neurodegeneration, Neurological disorders
Sponsor
King's College London
Enrollment
350
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32857151/ results (added 02/09/2020) 2017 Other publications in https://pubmed.ncbi.nlm.nih.gov/28774963/ (added 15/02/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32902934/ (added 15/02/2023)

Registry
who.int
Start Date
January 21, 2015
End Date
January 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults (aged 18 years or over) severely affected by advanced or progressive stages of the long\-term neurological conditions (LTNCs) of either\*:
  • 1\.1\. Multiple Sclerosis (MS) \- patients with either aggressive relapsing disease with rapid development of fixed disability or those with advanced primary or secondary progressive disease, often with limitation in a number of areas including gait and upper limb function. We do not define referral based on disability but would expect most patients to have an Expanded Disability Status Scale (EDSS) of at least 7\.5
  • 1\.2\. Parkinsonism \& related disorders (PRDs) i.e.
  • 1\.2\.1\. Idiopathic Parkinson’s Disease (IPD), Hoehn and Yahr (H\&Y) stages 4\-5 OR
  • 1\.2\.2\. Progressive Supranuclear Palsy (PSP) Hoehn and Yahr (H\&Y) stages 3\-5 OR
  • 1\.2\.3\. Multiple System Atrophy (MSA) \- Hoehn and Yahr (H\&Y) stages 3\-5
  • 1\.3\. Motor Neurone Disease (MND) all stages
  • 2\. Who are deemed (by referring/usual care clinicians) to have:
  • 2\.1\. An unresolved symptom (e.g. pain or another symptom) which has not responded to usual care
  • 2\.2\. AND at least one of the following: unresolved other symptoms (e.g. breathlessness, nausea/vomiting, spasticity, fatigue); cognitive problems; complex psychological (depression, anxiety, loss, family concerns), communication/information problems and/or complex social needs.

Exclusion Criteria

  • Patients who meet the inclusion criteria but:
  • 1\. Are already receiving specialist palliative care
  • 2\. Lack capacity and have no family member, friend or informal caregiver who is willing and available to complete questionnaires about their own and the patient’s symptoms and circumstances

Outcomes

Primary Outcomes

Not specified

Similar Trials